Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis

Gynecologic Oncology

Volumn 124, Issue 1, 2012, Pages 105-111

  Brunner, Andreas ^a   Hinterholzer, Susanne ^a   Riss, Paul ^a   Heinze, Georg ^b   Brustmann, Hermann ^b  

^a Landesklinikum Thermenregion Moedling/Vienna ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

B7 H3; Biomarker; Endometrial cancer; T cell; Tumor vasculature

Indexed keywords

B7 ANTIGEN; B7 H3 ANTIGEN; PARAFFIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER TISSUE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOTHELIUM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR VASCULARIZATION;

AGED; B7 ANTIGENS; BLOOD VESSELS; CARCINOMA, ENDOMETRIOID; CD8-POSITIVE T-LYMPHOCYTES; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 83055172736     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.09.012     Document Type: Article

References (43)

1. X. Zang, and J.P. Allison The B7 family and cancer therapy: costimulation and coinhibition Clin Cancer Res 13 2007 5271 5279 (Pubitemid 47510350)
2. B.M. Carreno, and M. Collins BTLA: a new inhibitory receptor with a B7-like ligand Trends Immunol 10 2003 524 527 (Pubitemid 37205202)
3. A.S. Freeman, G.J. Freeman, K. Rhynhart, and L.M. Nadler Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway Cell Immunol 137 1991 429 437
4. X. Zang, P. Loke, J. Kim, K. Murphy, R. Waitz, and J.P. Allison B7x: a widely expressed B7 family member that inhibits T cell activation Proc Natl Acad Sci U S A 100 2003 10388 10392 (Pubitemid 37071888)
5. D.L. Barber, E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, and A.H. Sharpe Restoring function in exhausted CD8 T cells during chronic viral infection Nature 439 2006 682 687 (Pubitemid 43237609)
6. M.G. Petroff, E. Kharatyan, D.S. Torry, and L. Holets The immunomodulatory poteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta Am J Pathol 167 2005 465 473 (Pubitemid 43026102)
7. X. Zang, P.S. Sullivan, R.A. Soslow, R. Waitz, V.E. Reuter, and A. Wilton Tumor associated endothel expression of B7-H3 predicts survival in ovarian carcinomas Mod Pathol 23 2010 1104 1112
8. P.L. Crispen, Y. Sheinin, T.J. Roth, C.M. Lohse, and S.M. Kuntz Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma Clin Cancer Res 14 2008 5150 5157
9. A.I. Chapoval, J. Ni, J.S. Lau, R.A. Wilcox, and D.B. Flies B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production Nat Immunol 2 2001 269 274 (Pubitemid 33706005)
10. Y. Suh, B.U. Gajewska, H. Okada, M.A. Gronski, and E.M. Bertram The B7 family member B/H3 preferentially down-regultes T helper type 1-mediated immune responses Nat Immunol 4 2003 899 906 (Pubitemid 37098661)
11. D.V. Prasad, T. Nguyen, Z. Li, and Y. Yang Murine B7-H3 is a negative regulator of T cells J Immunol 173 2004 2500 2506 (Pubitemid 39063108)
12. R.J. Greenwald, G.J. Freeman, and A.H. Sharpe The B7 family revisited Annu Rev Immunol 23 2005 515 548 (Pubitemid 40563179)
13. Y. Sun, Y. Wang, and J. Zhao B7-H3 and B7-H4 expression in non-small-cell lung cancer Lung Cancer 53 2006 143 151 (Pubitemid 43994236)
14. C.P. Wu, J.T. Jiang, M. Tan, and Y.B. Zhu Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis World J Gastroenterol 173 2004 457 459
15. T.J. Roth, Y. Sheinin, C.M. Lohse, and S.M. Kuntz B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Res 67 2007 7893 7900 (Pubitemid 47281385)
16. I. Yamato, M. Sho, T. Nomi, T. Akahori, and K. Shimada Clinical importance of B7-H3 expression in human pancreatic cancer Br J Cancer 101 2009 1709 1716
17. M. Loos, D.M. Hedderich, M. Ottenhausen, and N.A. Giese Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer BMC Cancer 9 2009 463
18. J. Sun, L.J. Chen, G.B. Zhang, and J.T. Jiang Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma Cancer Immunol Immunother 59 2010 1163 1171
19. FIGO Committee on Gynecologic Oncology The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas Gynecol Oncol 115 2009 325 328
20. Matias-Guiu X. Endometrial Neoplasia. In: Nucci MR, Oliva E, editors. Gynecologic Pathology. Elsevier Churchill Livingstone; 2009. p. 242-51.
21. S.G. Silverberg, and R.J. Kurman Atlas of tumor pathology Tumors of the uterine corpus and gestational trophoblastic disease, third series, fascicle 3 1992 Armed Forces Institute of Pathology Washington, D.C
22. W. Remmele, and H.E. Stegner Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Patholge 8 1987 138 140
23. W.T. Creasman, F. Odicino, and P. Maisonneuve Carcinoma of the corpus uteri. FIGO 6th annual report on the results of treatment in gynaecological cancer Int J Gynecol Obstet 95 2006 105 143
24. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
25. E.L. Kaplan, and P. Meier Non-parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
26. D.R. Cox Regression models and life-tables (with discussion) J R Stat Soc Series B 1972 34187 34220
27. L. Wang, C.C. Fraser, K. Kikly, A.D. Wells, and R. Han B7-H3 promotes acute and chronic allograft rejection Eur J Immunol 35 2005 428 438 (Pubitemid 40331320)
28. X. Zang, R.H. Thompson, H.A. Al-Ahmadie, and A.M. Serio B7-H3 and B7x are highly expressed in human prostate cancer and are associated with disease spread and poor outcome Proc Natl Acad Sci U S A 104 2007 19458 19463
29. Y. Sun, Y. Wang, J. Zhao, and M. Gu B7-H3 and B7-H4 expression in non-small-cell lung cancer Lung Cancer 53 2006 143 151 (Pubitemid 43994236)
30. R. Castriconi, A. Dondero, R. Augugliaro, and C. Cantoni Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from a NK cell-mediated lysis Proc Natl Acad Sci U S A 101 2004 12640 12645 (Pubitemid 39122076)
31. S. Kondratiev, E. Sabo, E. Yakirevich, O. Lavie, and M.B. Resnick Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma Clin Cancer Res 13 2004 4450 4456 (Pubitemid 38878888)
32. R.N. Germain, and D.M. Margulies The biochemistry and cell biology of antigen processing and presentation Annu Rev Immunol 11 1993 403 450 (Pubitemid 23115014)
33. T. Miyatake, B. Tringler, W. Liu, and J. Papkoff B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration Gynecol Oncol 106 2007 119 127 (Pubitemid 46898579)
34. S.A. Rosenberg Progress in human tumour immunology and immunotherapy Nature 411 2001 380 384 (Pubitemid 32467048)
35. R.J. Greenwald, G.J. Freeman, and A.H. Sharpe The B7 family revisited Annu Rev Immumol 23 2005 515 548 (Pubitemid 40563179)
36. K.A. Hofmeyer, A. Ray, and X. Zang The contrasting role of B7-H3 Proc Natl Acad Sci 105 2008 10277 10278
37. V. Ling, P.W. Wu, F. Spaulding, J. Kieleczawa, D. Luxenberg, and B.M. Carreno Duplication of primate and rodent B7-3 immunoglobulin V-and c-like domains: divergent history of functional redundancy and exon loss Genomoics 82 2003 365 377 (Pubitemid 36952307)
38. X. Sun, M. Vale, E. Leung, J.R. Kanwar, R. Gupta, and G.W. Krissansen Mouse B7-H3 induces antitumor immunity Gene Ther 10 2003 1728 1734 (Pubitemid 37121044)
39. L. Luo, A.I. Chapoval, D.B. Flies, and G. ZHU B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells J Immunol 173 2004 5445 5450 (Pubitemid 39392128)
40. L. Luo, H. Qiao, F. Meng, and X. Dong Arsenic trioxide synergizes with B7H3 mediated immunotherapy to eradicate hepatocellular carcinomas Int J Cancer 118 2006 1823 1830 (Pubitemid 43376449)
41. C.M. Lupu, C. Eisenbach, and M.A. Kuefner An orthtopic colon cancer model for studying the B7-H3 antitumor effect in vivo J Gastrointest Surg 10 2006 635 645 (Pubitemid 43711146)
42. C.M. Lupu, C. Eisenbach, and A.D. Lupu Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer Oncol Rep 18 2007 745 748
43. H. Xu, I.Y. Cheung, and H.F. Guo MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors Cancer Res 69 2009 6275 6281